ClinicalTrials.govpublic full text
Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX
colorectal cancer, nausea and vomiting, recurrent colon cancer, stage iv colon cancer, recurrent rectal cancer, stage iv rectal cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 915844
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.